MINCLE/CLEC4E, Human Antibody from NKMAX Co. Ltd.

Search, find, compare suppliers for anti-MINCLE/CLEC4E, Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMINCLE/CLEC4E, Human
CloneAT16E3
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG2b kappa
FormatProtein G purified
Size50ul, 100ul
Concentration1mg/ml (determined by BCA assay)
ApplicationsELISA, WB, ICC/IF, IHC, FACS
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCLEC4E (macrophage inducible C-type lectin, also called MINCLE or CLECSF9), which is a diverse family of protein which was originally defined by their ability to recognize a wide range of ligand of carbohydrate structure. CLEC4E expressed in macrophages subjected to several types of stress. It plays an essential role in response to trehalose-6, 6'-dimycolate (TDM) and activated by a synthetic analogue, trehalose dibehenate (TDB). Recently it was reported that CLEC4E is associated with an immunoreceptor tyrosine-based activation motif-containing Fc receptor gamma chain (FcRgamma) and functions as an activating receptor for damaged self- and non-self-pathogenic fungi.
ImmunogenRecombinant human MINCLE (41-219aa) purified from E.coli
Other NamesCLEC4E, CLECSF9, C-type lectin domain family 4 member E, C-type lectin superfamily member 9, Macrophage lectin 2, Macrophage-inducible C-type lectin, MINCLE, NtmntanCLEC4E Ege lectin 2
Gene, Accession #NCBI: NP_055173, UniProt: Q9ULY5
Catalog #ATGA0175
Price$170, $290
Order / More InfoMINCLE/CLEC4E, Human Antibody from NKMAX Co. Ltd.
Product Specific ReferencesSeifert L, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. (Nature. 2016){https://pubmed.ncbi.nlm.nih.gov/27049944/};;Zhao X, et al. Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages. (J Infect Dis. 2020){https://pubmed.ncbi.nlm.nih.gov/31562757/}
NKMAX Co. Ltd.
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124

salesbio@nkmax.com

http://www.nkmaxbio.com

Profile of NKMAX Co. Ltd.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.